Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 12,853 | 9,040 | -12,534 | 17,587 | 16,288 |
| Gross Profit | 12,853 | 9,040 | -12,534 | 17,587 | 16,288 |
| Operating Expenses | 42,907 | 41,102 | 46,035 | 40,228 | 35,493 |
| Operating Income | -30,054 | -32,062 | -58,569 | -22,641 | -19,205 |
| Other Income | 558 | 81 | 80 | 57 | -38 |
| Pre-tax Income | -29,496 | -31,981 | -58,489 | -22,584 | -19,243 |
| Net Income Continuous | -29,496 | -31,981 | -58,489 | -22,584 | -19,243 |
| Net Income | $-29,496 | $-31,981 | $-58,489 | $-22,584 | $-19,243 |
| EPS Basic Total Ops | -0.45 | -0.49 | -0.90 | -0.35 | -0.30 |
| EPS Basic Continuous Ops | -0.45 | -0.49 | -0.91 | -0.35 | -0.30 |
| EPS Diluted Total Ops | -0.45 | -0.49 | -0.90 | -0.35 | -0.30 |
| EPS Diluted Continuous Ops | -0.45 | -0.49 | -0.91 | -0.35 | -0.30 |
| EBITDA(a) | $-29,460 | $-31,477 | $-57,909 | $-21,955 | $-18,388 |